The Efficacy of Binary Ethylenimine-inactivated Vaccines of Gianyar-1/AK/2014 Virulent Strain in Protecting Chickens Against Tabanan-1/ARP/2017 Virulent Newcastle Disease Virus Isolates

Overview

Journal Vet World

Specialty Veterinary Medicine

Date 2019 Aug 24

PMID 31439989

Citations 3

Authors

Anak Agung Ayu Mirah Adi

I Nyoman Mantik Astawa

I Gusti Agung Arta Putra

Affiliations

Soon will be listed here.

Abstract

Aim: This study aimed to prepare binary ethylenimine (BEI)-inactivated virulent Newcastle disease virus (NDV) vaccine and to examine their ability to induce a protective antibody response in commercial chickens.

Materials And Methods: A virulent NDV field isolate Gianyar-1/AK/2014 was propagated in chicken-embryonated eggs and was then inactivated with BEI at a concentration of 4 mM. Three groups of chickens with low-level (2 log hemagglutination inhibition [HI] units) maternally derived antibodies against NDV were then immunized with the BEI-inactivated vaccine. A commercial live vaccine (LaSota strain) was used as positive control, and phosphate-buffered saline (PBS) was used as negative control. A challenge experiment with a virulent NDV of Tabanan-1/ARP/2017 was performed at 3 weeks post-vaccination.

Results: At 2 weeks post-immunization, the mean titers of antibodies against NDV in serum samples of chickens immunized with 0.2 mL of BEI-inactivated NDV (Group I), with live commercial NDV vaccine (Group II) and with PBS (Group III) were 3±0.94 log HI units, 4.9±0.99 log HI unit, and 0.0±0.0 HI units, respectively. At week 3 post-immunization, the mean titers of the antibodies for the three groups were 5±1.09 log HI units, 6.9±0.32 log HI units, and 0.00 HI units, respectively. The antibody titer induced by inactivated NDV Gianyar-1/AK/2014 isolates examined at 2 and 3 weeks post-vaccination was still at a significantly (p<0.01) lower level as compared to those induced by commercial life vaccine. However, the challenge test with virulent NDV of Tabanan 1/ARP/2017 isolates showed that all immunized chickens (Group I and II) survived without exhibiting any clinical sign post-challenge with the protection rates of 100%, whereas all chickens injected with PBS (Group III) died with clinical signs of ND.

Conclusion: This finding shows that the BEI-inactivated vaccines prepared using virulent NDV of Gianyar-1/AK/2014 strain was able to induce protective antibody response in chickens but still at a lower level than those induce by commercial live NDV vaccine.

Citing Articles

Humoral, cellular immunity and efficacy of bioreactor propagated and inactivated Fowl adenovirus 8b adjuvanted with Montanide 71VG in broiler chickens.

Ugwu C, Hair-Bejo M, Nurulfiza M, Omar A, Ideris A J Adv Vet Anim Res. 2024; 11(3):693-702.

PMID: 39605767 PMC: 11590594. DOI: 10.5455/javar.2024.k819.

Assessment of Different Newcastle Disease Virus Antigens and Inactivators of Binary Ethylene Amine and Formalin for the Hemagglutination Inhibition Assay.

Rahmanzad F, Amini Najafi F, Bahonar A, Parvandar Asadollahi K Arch Razi Inst. 2024; 79(2):437-444.

PMID: 39463717 PMC: 11512190. DOI: 10.32592/ARI.2024.79.2.437.

Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in Mice.

Kim N, Lee T, Lee H, Yang J, Kim K, Lee J Vaccines (Basel). 2022; 10(11).

PMID: 36366352 PMC: 9693512. DOI: 10.3390/vaccines10111843.

References

Zhao J, Yang H, Xu H, Ma Z, Zhang G . Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza. Virol J. 2017; 14(1):56. PMC: 5356287. DOI: 10.1186/s12985-017-0723-7. View

Bonnafous P, Nicolai M, Taveau J, Chevalier M, Barriere F, Medina J . Treatment of influenza virus with beta-propiolactone alters viral membrane fusion. Biochim Biophys Acta. 2013; 1838(1 Pt B):355-63. DOI: 10.1016/j.bbamem.2013.09.021. View

Delrue I, Verzele D, Madder A, Nauwynck H . Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges. Expert Rev Vaccines. 2012; 11(6):695-719. DOI: 10.1586/erv.12.38. View

Koppad S, Raj G, Gopinath V, John Kirubaharan J, Thangavelu A, Thiagarajan V . Calcium phosphate coupled Newcastle disease vaccine elicits humoral and cell mediated immune responses in chickens. Res Vet Sci. 2010; 91(3):384-90. DOI: 10.1016/j.rvsc.2010.09.008. View

Kim D, Huey D, Oglesbee M, Niewiesk S . Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies. Blood. 2011; 117(23):6143-51. PMC: 3122939. DOI: 10.1182/blood-2010-11-320317. View

Abdi R, Amsalu K, Merera O, Asfaw Y, Gelaye E, Yami M . Serological response and protection level evaluation in chickens exposed to grains coated with I2 Newcastle disease virus for effective oral vaccination of village chickens. BMC Vet Res. 2016; 12(1):150. PMC: 4959049. DOI: 10.1186/s12917-016-0785-6. View

Courtney S, Susta L, Gomez D, Hines N, Pedersen J, Brown C . Highly divergent virulent isolates of Newcastle disease virus from the Dominican Republic are members of a new genotype that may have evolved unnoticed for over 2 decades. J Clin Microbiol. 2012; 51(2):508-17. PMC: 3553931. DOI: 10.1128/JCM.02393-12. View

Adi A, Astawa N, Putra K, Hayashi Y, Matsumoto Y . Isolation and characterization of a pathogenic Newcastle disease virus from a natural case in indonesia. J Vet Med Sci. 2009; 72(3):313-9. DOI: 10.1292/jvms.09-0303. View

De Vriese J, Steensels M, Palya V, Gardin Y, Dorsey K, Lambrecht B . Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny. Avian Dis. 2010; 54(1 Suppl):246-52. DOI: 10.1637/8908-043009-Reg.1. View

10.

Kapczynski D, Afonso C, Miller P . Immune responses of poultry to Newcastle disease virus. Dev Comp Immunol. 2013; 41(3):447-53. DOI: 10.1016/j.dci.2013.04.012. View

11.

Cornax I, Miller P, Afonso C . Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype. Avian Dis. 2012; 56(3):464-70. DOI: 10.1637/10043-122011-Reg.1. View

12.

Sarkar A, Tamil Selvan R, Kishore S, Ganesh K, Bhanuprakash V . Comparison of different inactivation methods on the stability of Indian vaccine strains of foot and mouth disease virus. Biologicals. 2017; 48:10-23. DOI: 10.1016/j.biologicals.2017.06.004. View

13.

Rauw F, Gardin Y, Palya V, Van Borm S, Gonze M, Lemaire S . Humoral, cell-mediated and mucosal immunity induced by oculo-nasal vaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle disease vaccines. Vaccine. 2009; 27(27):3631-42. DOI: 10.1016/j.vaccine.2009.03.068. View

14.

Mondal S, Neelima M, Seetha Rama Reddy K, Ananda Rao K, Srinivasan V . Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production. Biologicals. 2005; 33(3):185-9. DOI: 10.1016/j.biologicals.2005.05.003. View

15.

Jagt H, Bekkers M, van Bommel S, van der Marel P, Schrier C . The influence of the inactivating agent on the antigen content of inactivated Newcastle disease vaccines assessed by the in vitro potency test. Biologicals. 2009; 38(1):128-34. DOI: 10.1016/j.biologicals.2009.07.006. View

16.

Xiao S, Nayak B, Samuel A, Paldurai A, Kanabagattebasavarajappa M, Prajitno T . Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain. PLoS One. 2013; 7(12):e52751. PMC: 3528709. DOI: 10.1371/journal.pone.0052751. View

17.

Habib M, Hussain I, Irshad H, Yang Z, Shuai J, Chen N . Immunogenicity of formaldehyde and binary ethylenimine inactivated infectious bursal disease virus in broiler chicks. J Zhejiang Univ Sci B. 2006; 7(8):660-4. PMC: 1533761. DOI: 10.1631/jzus.2006.B0660. View

18.

Cornax I, Diel D, Rue C, Estevez C, Yu Q, Miller P . Newcastle disease virus fusion and haemagglutinin-neuraminidase proteins contribute to its macrophage host range. J Gen Virol. 2013; 94(Pt 6):1189-1194. PMC: 3709627. DOI: 10.1099/vir.0.048579-0. View

19.

Lardinois A, van den Berg T, Lambrecht B, Steensels M . A model for the transfer of passive immunity against Newcastle disease and avian influenza in specific pathogen free chickens. Avian Pathol. 2014; 43(2):118-24. DOI: 10.1080/03079457.2014.880407. View

20.

Yang D, Kim H, Lee K, Song J . The present and future of rabies vaccine in animals. Clin Exp Vaccine Res. 2013; 2(1):19-25. PMC: 3623496. DOI: 10.7774/cevr.2013.2.1.19. View